You are here

  • Home
  • Archive
  • Volume 13, Issue 6
  • Influence of comorbidities on treatment considerations for first-line biologic prescribing in patients with inflammatory bowel disease in the UK

Article metrics

Article menu

Download PDFPDF

Professional matters
Original research
Influence of comorbidities on treatment considerations for first-line biologic prescribing in patients with inflammatory bowel disease in the UK

 

Online download statistics by month:

Online download statistics by month: March 2022 to March 2024

AbstractFullPdf
Mar 202218116524
Apr 202223722631
May 202213012223
Jun 202213613036
Jul 2022696717
Aug 2022838514
Sep 20229810026
Oct 2022339345113
Nov 202224725577
Dec 202214113929
Jan 202310210026
Feb 202310110422
Mar 202310410633
Apr 202312312331
May 202312212143
Jun 2023737145
Jul 2023919020
Aug 202322522562
Sep 202312513233
Oct 202313713834
Nov 202313112624
Dec 2023807642
Jan 202411410742
Feb 2024575719
Mar 2024989463
Total33443304929